CLINICAL_TRIALS
trial_result
· 2023-01-03
Clinical Trial Update: Macular Pigment and Visual Performance in Glaucoma Patients [Phase 1, Phase 2]
Summary
Phase 1/2 trial in glaucoma investigating macular pigment and visual performance has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Felipe Medeiros, MD | Conditions: Glaucoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-01-03